Literature DB >> 16949372

Acyl-phosphates initiate membrane phospholipid synthesis in Gram-positive pathogens.

Ying-Jie Lu1, Yong-Mei Zhang, Kimberly D Grimes, Jianjun Qi, Richard E Lee, Charles O Rock.   

Abstract

It is not known how Gram-positive bacterial pathogens carry out glycerol-3-phosphate (G3P) acylation, which is the first step in the formation of phosphatidic acid, the key intermediate in membrane phospholipid synthesis. In Escherichia coli, acylation of the 1-position of G3P is carried out by PlsB; however, the majority of bacteria lack a plsB gene and in others it is not essential. We describe a two-step pathway that utilizes a new fatty acid intermediate for the initiation of phospholipid formation. First, PlsX produces a unique activated fatty acid by catalyzing the synthesis of fatty acyl-phosphate from acyl-acyl carrier protein, and then PlsY transfers the fatty acid from acyl-phosphate to the 1-position of G3P. The PlsX/Y pathway defines the most widely distributed pathway for the initiation of phospholipid formation in bacteria and represents a new target for the development of antibacterial therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949372     DOI: 10.1016/j.molcel.2006.06.030

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  64 in total

1.  Genome sequence and analysis of the soil cellulolytic actinomycete Thermobifida fusca YX.

Authors:  Athanasios Lykidis; Konstantinos Mavromatis; Natalia Ivanova; Iain Anderson; Miriam Land; Genevieve DiBartolo; Michele Martinez; Alla Lapidus; Susan Lucas; Alex Copeland; Paul Richardson; David B Wilson; Nikos Kyrpides
Journal:  J Bacteriol       Date:  2007-01-05       Impact factor: 3.490

Review 2.  Acyltransferases in bacteria.

Authors:  Annika Röttig; Alexander Steinbüchel
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  Fatty acid activation and utilization by Alistipes finegoldii, a representative Bacteroidetes resident of the human gut microbiome.

Authors:  Christopher D Radka; Matthew W Frank; Charles O Rock; Jiangwei Yao
Journal:  Mol Microbiol       Date:  2020-01-06       Impact factor: 3.501

Review 4.  Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?

Authors:  Joshua B Parsons; Charles O Rock
Journal:  Curr Opin Microbiol       Date:  2011-08-20       Impact factor: 7.934

Review 5.  Knowns and unknowns of membrane lipid synthesis in streptomycetes.

Authors:  Mario Sandoval-Calderón; Ziqiang Guan; Christian Sohlenkamp
Journal:  Biochimie       Date:  2017-05-15       Impact factor: 4.079

Review 6.  Bacterial fatty acid metabolism in modern antibiotic discovery.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-23       Impact factor: 4.698

7.  Bacteria possessing two RelA/SpoT-like proteins have evolved a specific stringent response involving the acyl carrier protein-SpoT interaction.

Authors:  Aurélia Battesti; Emmanuelle Bouveret
Journal:  J Bacteriol       Date:  2008-11-07       Impact factor: 3.490

8.  Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus.

Authors:  Joshua B Parsons; Jiangwei Yao; Matthew W Frank; Pamela Jackson; Charles O Rock
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

Review 9.  How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

10.  Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis.

Authors:  Pooja Arora; Aneesh Goyal; Vivek T Natarajan; Eerappa Rajakumara; Priyanka Verma; Radhika Gupta; Malikmohamed Yousuf; Omita A Trivedi; Debasisa Mohanty; Anil Tyagi; Rajan Sankaranarayanan; Rajesh S Gokhale
Journal:  Nat Chem Biol       Date:  2009-02-01       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.